ABSTRACT Mon1 is an evolutionarily conserved protein involved in the conversion of Rab5 positive early endosomes to late endosomes through the recruitment of Rab7. We have identified a role for Drosophila Mon1 in regulating glutamate receptor levels at the larval neuromuscular junction. We generated mutants in Dmon1 through P-element excision. These mutants are short-lived with strong motor defects. At the synapse, the mutants show altered bouton morphology with several small supernumerary or satellite boutons surrounding a mature bouton; a significant increase in expression of GluRIIA and reduced expression of Bruchpilot. Neuronal knockdown of Dmon1 is sufficient to increase GluRIIA levels, suggesting its involvement in a presynaptic mechanism that regulates postsynaptic receptor levels. Ultrastructural analysis of mutant synapses reveals significantly smaller synaptic vesicles. Overexpression of vglut suppresses the defects in synaptic morphology and also downregulates GluRIIA levels in Dmon1 mutants, suggesting that homeostatic mechanisms are not affected in these mutants. We propose that DMon1 is part of a presynaptically regulated transsynaptic mechanism that regulates GluRIIA levels at the larval neuromuscular junction.
S
YNAPTIC strength is tightly modulated through expression of presynaptic and postsynaptic proteins. The regulation occurs at the level of transcription, translation, or degradation via the ubiquitin-proteosome and lysosomal pathways (DiAntonio et al. 2001; Dobie and Craig 2007; Fernandez-Monreal et al. 2012) . The larval neuromuscular junction (NMJ) in Drosophila is glutamatergic and serves as an excellent system to study regulation of receptor levels-one of the key factors underlying synaptic strength and functional plasticity.
During development, expression of the glutamate receptor subunits, including GluRIIA, is regulated by Lola-a BTB Zn-finger domain transcription factor in an activity-dependent manner (Fukui et al. 2012) . The abundance of the receptor at the synapse is sensitive to presynaptic inputs and is subject to translational control by RNA binding proteins and microRNAs (Sigrist et al. 2000 (Sigrist et al. , 2003 Menon et al. 2004; Heckscher et al. 2007; Karr et al. 2009; Menon et al. 2009 ). The precise mechanism that controls this regulation is not clear. In addition, the role of endocytic pathways in regulating glutamate receptor levels through trafficking to and from the synapse, as well as the molecular pathways governing protein turnover are still poorly understood.
Endocytic vesicles carrying cell surface proteins such as signaling molecules, cellular organelles, and engulfed pathogens sort their cargo such that they are either recycled or targeted to the lysosome for degradation. The trafficking of these vesicles, through fusion with appropriate membrane compartments, is regulated by Rab GTPases-a family of small G-proteins. Mon1 was first identified in yeast as a protein, which in complex with CCZ1, regulates all fusion events to the lysosome (Wang et al. 2002 (Wang et al. , 2003 . Subsequent studies in Caenorhabditis elegans identified SAND-1/Mon1 as an effector of Rab5, and as a factor essential for recruitment of Rab7, highlighting its role in the conversion of Rab5 positive early endosome to Rab7 containing late endosome (Poteryaev et al. 2007; Kinchen and Ravichandran 2010; Poteryaev et al. 2010) . Consistent with these studies, loss of Mon1 in Drosophila is shown to result in enlarged endosomes and loss of endosomal Rab7, implying a role for DMon1 in the recruitment of Rab7 (Yousefian et al. 2013) .
We are interested in pathways that regulate synaptic function for their implication in motor neuron disease (Ratnaparkhi et al. 2008) . We isolated a mutation in Mon1 while screening for P-element excisions in the neighboring gene pog. A striking phenotype observed in these mutants was their inability to walk or climb normally. The presence of a strong motor defect implied impaired neuronal or muscle dysfunction that prompted us to examine these mutants in greater detail.
In this study, we describe a role for Drosophila Mon1 (Dmon1) in regulating GluRIIA expression at the NMJ. Dmon1 mutants show multiple synaptic phenotypes. A striking phenotype among these is the huge increase in postsynaptic GluRIIA levels. The increase in receptor levels appears to be posttranscriptional, suggestive of control at the level or translation, trafficking, or protein degradation. We show that neuronal knockdown of Dmon1 is sufficient to phenocopy the GluRIIA phenotype, indicating the involvement of a presynaptic mechanism in regulating receptor levels. We find that Dmon1 mutants have smaller neurotransmitter vesicles, and overexpression of the vesicular glutamate transporter (vglut) suppresses the synaptic morphology and GluRIIA phenotype in Dmon1 mutants. Our results thus suggest a novel role for DMon1 in regulating GluRIIA levels, which we hypothesize may, in part, be via a mechanism linked to neurotransmitter release.
Materials and Methods

Generation and mapping of Mon1 mutants
The mutants Dmon1 D181 and Dmon1 D129 were generated by excising the pUAST-Rab21::YFP insertion (Bloomington Drosophila Stock Center) using standard genetic methods. D181 and D129 failed to complement each other and deficiency lines Df (2L) 9062, Df (2L) 6010, and Df(2L)8012, which span the genomic locus, but showed complementation to mRpS2 EY10086 (Mathew et al. 2009) , suggesting that the deletion does not extend to mRpS2.
Molecular mapping was carried out using PCR on genomic DNA isolated from homozygous third instar mutant larvae identified using second chromosome GFP balancers. To map the deletion, the entire region spanning genes Dmon1 and pog was analyzed by PCR.
Primers 11926_2F and primer 31660_Ex2R ( Figure 1A , gray arrows) amplified a 850-bp product with D181 (2128 bases in wild type). This was cloned and sequenced to determine the breakpoints of the deletion. In D129 mutants, primers 3F in CG11926 and Int1_R2 in CG31660/pog ( Figure 1A , red arrows) amplified a 550-bp band instead of the expected 2.4 kb. The pog primer sequences used for mapping include: Ex 31660_1F, ACTGGTGCTGGCCGACCGCTC; Ex31660_2R, AACCGACAGA  TACACGAGCATT; Intron1, F1AATGCTCGTGTATCTGTCGGTT;  Intron1 F2, TGCCAGCATCAGGCTATCAAG; and Intron1 R2,  CTTGATAGCCTGATGCTGGCA. Dmon1 primers used for deletion mapping and RT-PCR are: 11926_1F, ATGGAAGTAGAGCA  GACGTCAGT; 11926_ 2F, AGCACGACAGTCTGTGGCAGG;  11926_ 3F, ATCTGCATGCGCATGTCTCGTAC; and 11926_ 4F, GAAACCATGCCACATTCTAAGCTT. The reverse primers were complementary to forward primers. Primers used for quantitative PCR include: RP49_forward, GACGCTTCAAGGGACAGTATC; RP49_reverse, AAACGCGGTTCTGCATGAG; GluRIIA_ forward, CGCACCTTCACTCTGATCTATG; and GluRIIA_reverse, CTGTCTCCTTCCACAATATCCG.
Drosophila stocks and fly husbandry
All stocks were reared on regular corn flour medium. The following fly stocks were used: pUAST-Rab21::YFP (no. 23242), Df(2L) 9062, and Df(2L)6010 were from the Bloomington Stock Center; Dmon1 RNAi line (GD38600) was obtained from the Vienna Drosophila RNAi Center (VDRC); UAS-dvglut and Sp/Cyo, wglacZ; UAS-mon1::HA were kind gifts from A. DiAntonio, Washington University, and T. Klein, University of Dusseldorf, respectively. Except where stated, all experiments were carried out at 25°.
Behavioral assays
Life span assays were carried out at 25°. The flies were monitored every day and transferred to fresh medium every other day. Measurement of climbing speed was carried out as described previously for spastin mutants (Sherwood et al. 2004) . Individually maintained, control and mutant flies were evaluated for climbing at 24-26 hr, 120 hr (day 5), and 192 hr (day 8) posteclosion. Each individual animal was subjected to three trials and the speed was calculated as the average of all three trials. Climbing ability was calculated by scoring for the number of flies that climbed 6 cm in 5 sec.
Immunohistochemistry and image analysis
Wandering third instar larvae were dissected in PBS and fixed with Bouins fixative (15 min). The following antibodies were used: anti-FasciclinII or mAb1D4 (1:15 or 1:25, Developmental Studies Hybridoma Bank (DSHB); mAbnc82 (1:50, DSHB); anti-GluRIIA/mAb8B4D2 (1:200, ascites; DSHB); anti-HRP (1:1000, Sigma-Aldrich); anti-Rab5 [1:200 (for Figure 5 ) and 1:500, AbCam]; anti-HA (1:200, Sigma, no. 9658); anti-Rab7 (1:100) (Chinchore et al. 2009 ); and anti-GluRIIB and anti-vGlut (1:2000 and 1:500, gift from A. DiAntonio and Herman Aberle respectively). For anti-GluRIIB staining, animals were fixed for 1 min in Bouins fixative. For anti-Rab5 and anti-Rab7, animals were fixed using 4% paraformaldehyde for 20 min. Confocal imaging was carried out on a Zeiss 710 imaging system at Indian Institute of Science Education and Research (IISER). All confocal images were taken using a 633 objective (N.A. = 1.4).
Image analysis and fluorescence intensity measurements were carried out using ImageJ software (National Institutes of Health, NIH, Bethesda). Quantititation of GluRIIA and GluRIIB levels was carried out using the method described previously in Menon et al. (2009) . The average gray value per synapse was determined by measuring the intensity of three individual boutons. In each case, the measured values were normalized to the background intensity for the same area. Since the mutants show significant GluRIIA staining in muscles, a region of the nucleus or regions free of GluRIIA staining was chosen for background normalization.
Analysis of the size and intensity of Brp punctae was carried out as described in Dickman et al. (2006) . Briefly, three times the background was subtracted from the image and the resulting image was duplicated. One duplicate image was converted to binary and segmented using the watershed algorithm. Puncta size was measured from the segmented binary image using the "analyze particles" tool in ImageJ and intensity using the "redirect" option referring to the nonbinary image in the "set measurements" option. Control and experimental larvae used for quantitation were processed simultaneously for immunostaining. A master mix of the antibodies at appropriate dilutions was made prior to addition to individual tubes. Imaging was carried out under identical confocal settings. Figures were assembled using Adobe Photoshop CS4 and PowerPoint. Statistical analysis (Student's t-test and one-way ANOVA for Figure  4 ) was carried out using Sigma Plot 10. The 3D volume rendering of the bouton for Figure 7 was carried out using IMARIS software at IISER.
TEM analysis
Wild-type and mutant third instar larvae were processed for electron microscopy as described (Ratnaparkhi et al. 2008) . Briefly, the larvae were dissected in PBS and fixed for 2 hr with 2% glutaraldehyde in 0.12 M sodium cacodylate buffer (pH 7.4). Samples were postfixed with 1% osmium tetroxide in 0.12 M sodium cacodylate with rotation. Staining with 2% uranyl acetate was carried out en bloc for at least 1 hr. The samples were washed, dehydrated using an ethanol series, and embedded in araldite resin. Analysis was carried out on a FEI Tecnai G2 spirit, 120 Kv transmission electron microscope. Type 1b boutons from segments A2 and A3 were imaged and used for analysis. Electron micrographs were analyzed using ImageJ. A total of 200 vesicles from 10 boutons (wild type, four animals) and 100 vesicles from 7 boutons (three animals) were used for quantitation. In most cases, vesicles near active zones were chosen for analysis.
Real-time PCR
Third instar larvae were dissected in PBS and RNA was isolated from body wall muscles of the larvae using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. An equal amount of RNA from W1118 (control) and D181 larvae was used for cDNA synthesis. Real-time PCR was performed for rp49 and GluRIIA with SYBR green mix (Kappa Biosystem) on an Eppendorf RealPlex2. The fold change was calculated using 2 2D(DCT) . 
Data availability
Supplemental information present in Figure S1 , Figure S2 , and Figure S3 .
Results
Dmon1 mutants have lifespan and motor defects
We generated and identified a mutation in Dmon1 through imprecise excision of pUASt-YFP::Rab21 located at the 39 end of Dmon1 and 59 upstream of its neighbor pog. Two of the putative excision lines D129 and D181 failed to complement the deficiencies spanning the locus. Molecular mapping using PCR revealed the excision in D129 to span the 39 end of Dmon1 and 59 end of pog. The deletion in D181 was restricted to Dmon1, extending from position 4851580 in the second intron to 4852858-5 bases upstream of the transcription start site of CG31660 ( Figure 1A) . Details of the excision and molecular mapping are described in Materials and Methods. RT-PCR analysis of D181 showed that these mutants express a truncated transcript corresponding to residues 1-248 of the protein sequence. A full-length transcript was not detected in the mutants-a result consistent with the molecular nature of the mutation (Supporting Information, Figure  S1 , C and D). Using RT-PCR, we also confirmed that the deletion in D181 does not affect expression of the neighboring pog gene ( Figure S1E ).
Homozygous Dmon1 D181 mutants die throughout development and during eclosion. The escaper adults are weak and usually die within 7 days. We measured the life span of Dmon1 D181 mutants as homozygotes and in combination with the deficiencies that span the locus. Homozygous Dmon1 D181 mutants show a severe lifespan defect: 50% of the animals survive ,5 days. In case of Dmon1 D181 /Df(2L) 9062 and Dmon1 D181 /Df(2L)6010, the half-life of the animals was approximately 7 and 18 days, respectively ( Figure  1B ). Expression of a HA-tagged Dmon1 (UAS-Dmon1::HA) using the pan-neuronal driver C155-GAL4, rescued the life span defect in Dmon1 D181 /Df(2L)9062 mutants ( Figure 1B ), indicating that lethality and reduced life span were due to loss of Dmon1.
Dmon1 mutants that eclose are slow and unable to climb. We quantified this defect by measuring the climbing speed and climbing ability of Dmon1 D181 and Dmon1 D181 /Df(2L) 9062 mutant animals 24 hr posteclosion. Wild-type and Dmon1 D181 /+ animals did not show any significant difference in their average climbing speed [2.18 6 0.48 (n = 34) sec vs. 2.5 6 0.66 (n = 48) sec, respectively]. No significant change in speed was observed on day 5 [2.32 6 0.58 (n = 34) vs. 2.77 6 0.88 (n = 46) cm/sec, respectively] and day 8 [2.18 6 0.51 (n = 34) vs. 2.32 6 0.58 (n = 25), respectively] either. In contrast, the climbing speed of homozygous Dmon1 D181 , Dmon1 D181 /Df(2L)9062, and C155-GAL4; Dmon1 D181 /Df(2L)9062 animals was significantly lower on day 1 [0.37 6 0.28 (n = 21), 0.47 6 0.23 (n = 31), and 0.42 6 0.27 (n = 36) cm/sec, respectively; P , 0.001].
Pan-neuronal expression of Dmon1::HA in Dmon1 D181 / Df(2L)9062 rescued this defect: the average climbing speed of these animals (C155-GAL4; Dmon1 D181 /Df(2L)9062; UASDmon1::HA) was comparable to wild type [2.23 6 0.64 cm/sec, (n = 44) ( Figure 1C ) even though a small decrease in speed was observed on day 5 (2.03 6 0.64 cm/sec, (n = 42)] and day 8 [1.79 6 0.38 cm/sec, (n = 39)]. We measured climbing ability of the mutants by calculating the percentage of flies able to climb 6 cm in 5 sec. In wild-type and Dmon1 D181 /+ animals, .97% and 98% of the flies, respectively, were able to climb this distance in the specified time, whereas ,10% of Dmon1 D181 , Dmon1 D181 /Df(2L)9062, and C155-GAL4;Dmon1 D181 /Df(2L)9062 animals showed robust climbing ability ( Figure 1D ). Neuronal expression of Mon1:: HA using C155-GAL4 restored climbing ability to wild-type levels (98%, Figure 1D ). Thus, despite the difference in severity of lifespan between homozygous Dmon1 D181 and Dmon1 D181 /deficiency animals, there seemed to be little difference in their motor abilities. Dmon1 D181 mutants express a truncated transcript that encodes the longin domain. The longin domain of Mon1 is known to form homodimers with itself and heterodimers with the longin domain of its partner protein, CCZ1. It is possible that formation of nonfunctional dimers in Dmon1 D181 contributes to the increased serverity in lifespan (Nordmann et al. 2010 ).
Dmon1 mutants show accumulation of Rab5 positive endosomes:
In Drosophila and C. elegans loss of Mon1/SAND1 leads to accumulation of Rab5. These mutants also fail to recruit Rab7 onto endosomes (Poteryaev et al. 2007 (Poteryaev et al. , 2010 Kinchen and Ravichandran 2010) . To determine if homozygous Dmon1 D181 mutants exhibit a similar phenotype, we immunostained larval fillets for Rab5. In wild-type animals, small Rab5 positive puncta were seen distributed over the muscle (Figure 2 , B and C, white arrows in B) and in the presynaptic regions (Figure 2 , B and C, yellow arrows). In comparison, Dmon1 D181 mutants showed large scattered aggregates of Rab5, representing enlarged endosomes (Figure 2, E and F, arrows) . Similar Rab5 positive puncta were also seen in Dmon1 D181 /Df(2L)9062 and Dmon1 D181 /Df(2L) 6010 animals albeit smaller in size compared to Dmon1 D181 (data not shown). Similar to Rab5, expression of Rab7 in muscles appeared punctate in wild-type larvae, suggesting vesicular localization ( Figure 2H, inset) ; however, in Dmon1 D181 mutants, Rab7 staining appeared more diffuse, suggesting that localization, but not expression, of this protein is likely to be affected ( Figure 2K , inset). These results are consistent with the previous observations made in Drosophila and C. elegans, thus validating our loss-of-function allele (Kinchen and Ravichandran 2010; Yousefian et al. 2013 ).
Dmon1 D181 mutants exhibit altered synaptic morphology at the NMJ: The strong motor defect in Dmon1 D181 led us to examine the mutants for possible synaptic defects. A distinct change in synaptic morphology was observed at the neuromuscular junction in third instar larvae: most often, the boutons appeared large and surrounded by smaller supernumerary boutons (Figure 3 , D-F, arrows in inset). At times, the boutons appeared odd shaped, indicating fusion of two adjacent boutons ( Figure 3D , asterisk). Bouton size in mutant synapses was measured and compared to wild type by calculating the average diameter of boutons per synapse. In Dmon1 D181 mutants the average bouton size was significantly larger (3N; 5.46 6 0.74 mm, P , 0.001) than wild type (3N; 4.016 6 0.75 mm). Despite the difference in size, we did not observe any significant difference in bouton number between the two genotypes [10.87 6 3.46 (wild type) and 12 6 3.7 (Dmon1 D181 )].
The number of satellite boutons was also scored in these mutants. Dmon1 D181 animals showed a 250% increase in satellite boutons (5.6 6 2.57 in Dmon1 D181 vs. 1.61 6 1.66 in wild type). A similar increase was observed in Dmon1 D181 /Df(2L)9062 (7.38 6 3.01, 360%) and Dmon1 D181 /Df (2L)6010 animals (6.26 6 2.51, 290%), confirming that the phenotype is indeed due to loss of Dmon1 ( Figure 3M ).
Neuronal knockdown of Dmon1 using RNAi also led to an increase in bouton size (Figure 3 , J-L) with the average size being 4.78 6 0.55 mm (P , 0.001) compared to 3.26 6 0.49 mm in control animals ( Figure 3N ). However, unlike Dmon1 D181 , satellite boutons were not observed in these animals, suggesting that neuronal knockdown of Dmon1 alone may not be sufficient to give rise to the phenotype.
Expression of synaptic proteins Bruchpilot, GluRIIA, and GluRIIB is altered in Dmon1 D181 mutants: Mutations in trafficking genes are known to affect synaptic growth and neurotransmission (Littleton and Bellen 1995; Sanyal and Ramaswami 2002; Sweeney and Davis 2002; Dermaut et al. 2005) . To further characterize the synaptic phenotype in Dmon1 mutants, expression of presynaptic and postsynaptic markers was examined using immunostaining. Bruchpilot (Brp; mAb nc82) is a core protein involved in the assembly of active zones at the presynapse (Wagh et al. 2006) . Wild-type synapses showed strong punctate expression of Brp (Figure 4 , A-C, inset in C). In homozygous Dmon1 D181 mutants, a significant decrease in size (17.6%) and intensity (23%) of these puncta was observed (Figure 4, D-H) .
Next, we checked if glutamate receptor levels at postsynaptic densities were altered in Dmon1 D181 mutants. Synapses at the larval neuromuscular junction are glutamatergic. The postsynaptic ionotropic glutamate receptor consists of four subunits. Of these, subunits GluRIIC, GluRIID, and GluRIIE are invariant, with the fourth subunit being either GluRIIA or GluRIIB. Thus, two classes of glutamate receptor clusters are present at the synapse: those containing GluRIIA and others with GluRIIB . Interestingly, the mutants showed a strong increase in the intensity of GluRIIA staining (Figure 4 , L-N, inset in N). GluRIIA positive puncta were also seen in the muscle or extrasynaptic sites ( Figure 4M ). We measured the increase in fluorescence intensity by calculating the average gray value of GluRIIA normalized to HRP (Menon et al. 2004) . In Dmon1 D181 and Dmon1 D181 /Df(2L)6010 mutants, the increase in intensity was 74% and 56%, respectively, while Dmon1 D181 /Df(2L)9062 animals showed a 98% increase in GluRIIA intensity ( Figure 4O ).
The levels of GluRIIA and GluRIIB are reciprocally regulated at the synapse: an increase in GluRIIA leads to a decrease in GluRIIB (Petersen et al. 1997; DiAntonio et al. 1999; Sigrist et al. 2002; DiAntonio and Hicke 2004) . We therefore checked Dmon1 mutants for expression of GluRIIB to determine if the mutation affected both GluR subunits. Consistent with the reciprocal regulation of these receptor subunits, homozygous Dmon1 D181 mutants showed a distinct decrease in the intensity of GluRIIB at the synapse and absence of any extrasynaptic expression of the protein (Figure 4 , S-U and U9). We measured the decrease in fluorescence intensity of GluRIIB normalized to FasciclinII, whose level seemed comparable between wild-type and mutant animals. Dmon1 D181 mutants showed a 42% decrease in the intensity of GluRIIB, indicating the increase in receptor levels to be specific to GluRIIA, and that the mechanism controlling the homeostasis between GluRIIA and GluRIIB is unaffected.
We checked whether the increase in GluRIIA is due transcriptional up-regulation of the gene, by carrying out quantitative reverse transcriptase PCR. Interestingly, we did not observe any significant difference in transcript levels between wild-type and Dmon1 D181 animals. The calculated average fold difference was 1 and 0.89 6 0.22 (P = 0.47), respectively, suggesting that the specific increase in GluRIIA levels in the mutants is likely to be largely due to loss of posttranscriptional regulation.
Loss of neuronal Dmon1 is sufficient to alter the level of GluRIIA: Next, to determine the relative contribution of the pre-and postsynaptic compartments to the GluRIIA phenotype, RNAi was used to down-regulate Dmon1 in neurons and muscles. Compared to wild type ( Figure 5 , A-C, arrow in inset), expression of Dmon1 dsRNA using C155-GAL4; elav-GAL4 line-a line carrying two copies of the panneuronal GAL4-resulted in a 70% increase in fluorescence intensity of GluRIIA (Figure 5 , E-G) while a 32% increase was seen upon knockdown using the motor neuron-specific OK6-GAL4 ( Figure 5N ). In both experiments, an increase in GluRIIA positive extrasynaptic punctae was also observed. These 
arrows). (E and F) Dlg staining is unaltered in the mutants (E and F). (G-I)
elav-GAL4/+ and (J-L) elav-GAL4 . UASdsDmon1 animals immunostained with anti-HRP (red) and anti-Dlg (green). Expression of dsDmon1 results in bigger boutons (J). (M) Quantitation of satellite bouton number. Average number per synapse observed in w1118 is 1.61 6 1.66 (wild type, n = 41). Dmon1 D181 , Dmon1 D181 /Df(2L)9062, and Dmon1 D181 / Df(2L)6010 animals show 5.6 6 2.57, 7.38 6 3.01, and 6.26 6 2.51 satellite boutons per synapse, respectively (P , 0.001). (N) Quantitation of bouton size in wild type and Dmon1 mutants. The average bouton diameter (5.46 6 0.74 mm) in Dmon1 D181 animals is significantly larger than in wild type (4.01 6 0.75 mm). Expression of dsDmon1 in neurons results in larger boutons (4.78 6 0.55 mm) compared to controls (3.26 6 0.49 mm). Error bars represent SD.
results thus suggest that loss of Dmon1 in the presynaptic compartment is sufficient to trigger postsynaptic increase in GluRIIA.
To determine if neuronal overexpression of Dmon1 has an opposite effect on GluRIIA levels, we overexpressed UASDmon1::HA using the C155-GAL4; elav-GAL4 line. A 24% decrease in receptor levels was observed ( Figure 5 , G, L, and M). A decrease in receptor levels was also observed when the Dmon1 was overexpressed in the muscle (data not shown). This indicates that while loss of neuronal Dmon1 is sufficient to phenocopy the mutant GluRIIA phenotype, receptor levels can be modulated pre and postsynaptically by DMon1.
The synaptic phenotypes in Dmon1 mutants can be rescued by pre-and postsynaptic expression of Dmon1: To further confirm that the increase in GluRIIA is indeed due to loss of Dmon1, we checked if expression of the gene in the mutants rescues the synaptic phenotype. We expressed UASDmon1::HA presynaptically in homozygous Dmon1 D181 and Dmon1 D181 /Df(2L)9062 larvae and examined the receptor levels in these animals. Compared to mutants (Dmon1 D181 , elav-GAL4/Dmon1 D181 ; Figure 6 , A-C and C9), "rescue" animals expressing UAS-Dmon1::HA, showed a 48% decrease in the intensity of GluRIIA (Figure 6 , D-G). A significant decrease (27%) in GluRIIA levels was also observed in Dmon1 D181 /Df(2L)9062 mutants expressing Dmon1::HA ( Figure 6N ). Given the role of DMon1 in regulating endosomal trafficking it seemed possible that impaired cellular trafficking in the muscle might contribute to the increased accumulation of GluRIIA at the synapse. We therefore checked if postsynaptic expression of Dmon1 could rescue the GluRIIA phenotype. Expression of GluRIIA was significantly lowered in the "muscle-rescue" animals ( Figure 6 , K-M and M9). A near 70% decrease in the synaptic levels of GluRIIA was observed in these animals (0.12 6 0.05 in rescue vs. 0.39 6 0.15 in mutant control) ( Figure 6N ).
Interestingly, both presynaptic and postsynaptic expression of Dmon1 rescued the satellite bouton phenotype seen in the mutants ( Figure 6O ). Neuronal rescue of Dmon1 D181 /Df(2L) 9062 led to a 75% decrease in the number of satellite boutons (3.76 6 1.99 in mutant vs. 0.95 6 1.24 in neuronal rescue). A comparable decrease (80%) was observed in mutants expressing Dmon1 postsynaptically (4.25 6 2.51 in mutant "control" vs. 0.80 6 1.6 in muscle rescue larvae) ( Figure 6O ). Together, these results indicate that the synaptic phenotypes in Dmon1 mutants is indeed due to loss of the gene, and both presynaptic as well as postsynaptic expression of the gene can rescue these defects.
DMon1 is secreted at the neuromuscular junction: A study of the localization of Rabs in the ventral ganglion of third instar larvae suggests differential localization of each of these proteins (Chan et al. 2011) . Components of the endocytic machinery are also present at the NMJ and regulate vesicle recycling and formation of active zone complexes (Wucherpfennig et al. 2003; Graf et al., 2009) . To determine if DMon1 might play a role in any of the above processes, we sought to determine if the protein localizes to the synapse. We expressed UAS-Dmon1::HA in neurons and stained larval fillets using antibodies against the HA tag. In control (UAS-Dmon1::HA/+) animals, a few small puncta were seen dispersed around the area of the boutons (Figure 7 , A-C and C9). Interestingly, in elav-GAL4.UAS-Dmon1::HA animals, strong HA positive puncta were observed surrounding the bouton (Figure 7 , D-F and F9). The perisynaptic localization of Dmon1 was also observed when OK6-GAL4 was used to drive expression of UAS-Dmon1:: HA. To visualize the localization of DMon::HA more clearly, a 3D rendering of the images were examined. As shown in Figure 7F99 and F999, HA positive puncta were seen to be clearly surrounding the HRP positive presynaptic compartment. To further rule out possible staining artifacts caused by overexpression, localization of DMon1::HA was examined in Dmon1 D181 /Df(2L)9062 animals. Expression of DMon1::HA in a Dmon1 mutant background was also found to be perisynaptic, suggesting that the localization is unlikely to be an artifact caused by overexpression, although this needs to be tested more rigorously ( Figure S3 ). We tried to determine if the localization of DMon1 is dependent on Rab11 since it is required for exosomal secretion (Raposo and Stoorvogel 2013) . To do this, we coexpressed the tagged transgene with dominant negative Rab11 (DN-Rab11) in neurons. However, coexpression with DN-Rab11 led to widespread lethality, making it difficult evaluate this interaction.
We also examined anti-Dlg staining in animals overexpressing Dmon1. As opposed to the usual tight ring seen in control animals (Figure 7 , G-I and I9), Dlg staining was found to be broad and diffuse in animals overexpressing Dmon1:: HA (Figure 7 , J-L and L9). These results suggest that DMon1 localizes to the synapse and is likely to be released from the presynaptic compartment.
Neurotransmitter vesicle size is reduced in Dmon1 mutants: Expression of GluRIIA is dependent on cell-cell contact between the nerve and muscle (Karr et al. 2009; Ganesan et al. 2011; Fukui et al. 2012) . Further, homeostatic mechanisms regulate neurotransmitter release and postsynaptic receptor composition and density in response to presynaptic activity (Petersen et al. 1997; Davis et al. 1998; Schmid et al. 2008) . To gain further insight into the possible cause of increased GluRIIA accumulation, we examined the ultrastructure of boutons from wild type and Dmon1 D181 mutants. Interestingly, the mutants showed a distinct decrease in the size of synaptic vesicles (Figure 8, B and C) . In wild type, the average vesicle diameter measured 40.35 6 5.32 nma value comparable to what has been previously observed (Daniels et al. 2006) ; the mutants showed a 28.77% decrease in diameter with the average diameter being 28.74 6 7 nm.
One of the factors regulating vesicle size is dvglut, which encodes the vesicular glutamate transporter. Loss of dvglut leads to a decrease in size of synaptic vesicles while overexpression results in an increase in vesicle size and amplitude of spontaneous release (Daniels et al. 2004 (Daniels et al. , 2006 . We did not observe any significant change in vGlut/FasII ratios in Dmon1 D181 (2.05 6 0.67 in W1118 vs. 1.85 6 0.72 in Dmon1 D181 ). To determine if increasing glutamate release can down-regulate GluRIIA expression, we overexpressed dvglut in Dmon1 mutants and examined its effect on GluRIIA levels. Indeed, presynaptic overexpression of vglut in Dmon1 D181 /Df(2L)9062 animals resulted in a 49% decrease in postsynaptic GluRIIA levels and loss of extrasynaptic GluR-IIA (Figure 8, . A comparable decrease (43%) in receptor levels was observed when overexpression was carried out in a Dmon1 D181 background ( Figure 8J ). Expression of vGlut also suppressed the satellite bouton phenotype in Dmon1 mutants ( Figure 8K) . A 50% decrease in satellite bouton number was observed in Dmon1 D181 /Df(2L)9062 animals [control (4.82 6 2.6) vs. rescue (2.24 6 1.71)] while a 80% decrease was observed in homozygous Dmon1 D181 animals [mutant control (7.23 6 3.21) vs. rescue (1.33 6 1.34)]. This suggests that altered glutamate release in Dmon1 mutants could contribute to the increase in GluRIIA levels and postsynaptic homeostatic mechanisms are not affected in these mutants.
Discussion
Neurotransmitter release at the synapse is modulated by factors that control synaptic growth, synaptic vesicle recycling, and receptor turnover at postsynaptic sites (Sweeney and Davis 2002; Glodowski et al. 2007; Kim and Kandler 2010; Fernandes et al. 2014) . Endolysosomal trafficking modulates the function of these factors and therefore plays an important role in regulating synaptic development and function. Intracellular trafficking is regulated by Rabs, which are small GTPases. These proteins control specific steps in the trafficking process. A clear understanding of the role of Rabs at the synapse is still nascent. Drosophila has 31 Rabs, and most of these are expressed in the nervous system (Chan et al. 2011) . Rab5 and Rab7, present on early and late endosomes, respectively, are critical regulators of endolysosomal trafficking and loss of this regulation affects neuronal viability underscored by the fact that mutations in Rab7 are associated with neurodegeneration (Verhoeven et al. 2003) . Rab5 along with Rab3 is present on synaptic vesicles, and both play a role in regulating neurotransmitter release (Fischer Von Mollard et al. 1994a,b; Sudhof 1995) . In Drosophila, Rab3 is involved in the assembly of active zones by controlling the level of both Bruchpilot-a core active zone protein-and the calcium channels surrounding the active zone (Graf et al. 2009 ). In hippocampal and cortex neurons, Rab5 facilitates LTD through removal of AMPA receptors from the synapse (Brown et al. 2005; Zhong et al. 2008) . In Drosophila, Rab5 regulates neurotransmission; it also functions to maintain synaptic vesicle size by preventing homotypic fusion (Shimizu et al. 2003; Wucherpfennig et al. 2003) . Compared to Rab5 or Rab3, less is known about the roles of Rab7 at the synapse. In spinal cord motor neurons, Rab7 mediates sorting and retrograde transport of neurotrophin-carrying vesicles (Deinhardt et al. 2006) . In Drosophila, tbc1D17-a known GAP for Rab7-affects GluRIIA levels (Lee et al. 2013) ; the effect of this on neurotransmission has not been evaluated. Excessive trafficking via the endolysosomal pathway also affects neurotransmission. This has been observed in mutants for tbc1D24-a GAP for Rab35. A high rate of turnover of synaptic vesicle proteins in these mutants is seen to increase neurotransmitter release (Uytterhoeven et al. 2011; Fernandes et al. 2014) .
In this study we have examined the synaptic role of DMon1-a key regulator of endosomal maturation. Multiple synaptic phenotypes are found associated with Dmon1 loss of function, and one of these is altered synaptic morphology. Boutons in Dmon1 mutants are larger with more satellite or supernumerary boutons (Figure 3 )-a phenotype strongly associated with endocytic mutants (Dickman et al. 2006) . Formation of satellite boutons is thought to occur due to loss of bouton maturation, with the initial step of bouton budding being controlled postsynaptically and the maturation step being regulated presynaptically (Lee and Wu 2010) . Supporting this, a recent study shows that miniature neurotransmission is required for bouton maturation (Choi et al. 2014) . The presence of excess satellite boutons in Dmon1 mutants suggests that the number of "miniature" events is likely to be affected in these mutants. The fact that we can rescue this phenotype upon expression of vGlut supports this possibility ( Figure 8 ). However, this does not fit with the observed decrease in size and intensity of Brp positive puncta in these mutants. Active zones with low or nonfunctional Brp are known to be more strongly associated with increased spontaneous neurotransmission (Melom et al. 2013; Peled et al. 2014) . Considering the involvement of postsynaptic signaling in initiating satellite bouton formation, we think altered neurotransmission possibly together with impaired postsynaptic or retrograde signaling, contributes to the altered synaptic morphology in Dmon1 mutants. This may also explain why we fail to observe satellite boutons in neuronal RNAi animals.
A striking phenotype associated with loss of Dmon1 is the increase in GluRIIA levels (Figure 4 ). This phenotype seems presynaptic in origin since neuronal loss of Dmon1 is sufficient to increase GluRIIA levels ( Figure 5 ). Is the increase in GluRIIA due to trafficking defects in the neuron? This seems unlikely for the following reasons: First, it has been shown that although neuronal overexpression of wild-type and dominant negative Rab5 alters evoked response in a reciprocal manner, there is no change in synaptic morphology, glutamate receptor localization and density, or change in synaptic vesicle size (Wucherpfennig et al. 2003) . The role of Rab7 at the synapse is less clear. In a recent study, loss of tbc1D15-17, which functions as a GAP for Rab7, was shown to increase GluRIIA levels at the synapse. Selective knockdown of the gene in muscles, and not neurons, was seen to increase GluR-IIA levels, indicating that the function of the gene is primarily postsynaptic (Lee et al. 2013) . These data are not consistent with our results from neuronal knockdown of Dmon1, suggesting that the presynaptic role of Dmon1 in regulating GluRIIA levels is likely to be independent of Rab5 and Rab7 and therefore novel.
Our experiments to evaluate the postsynaptic role of Dmon1 have been less clear. Although we see a modest increase in GluRIIA levels upon knockdown in muscles, the increase is not always significant when compared to controls (data not shown). However, the fact that muscle expression of Dmon1 can rescue the GluRIIA phenotype in the mutant (Figure 6 ) suggests that it is likely to be one of the players in regulating GluRIIA postsynaptically. Further, it is to be noted, that while overexpression of vGlut leads to down-regulation of the receptor at the synapse (Figure 8 ), the receptors do not seem to get trapped in the muscle, suggesting that multiple pathways are likely to be involved in regulating receptor turnover in the muscle, and the DMon1-Rab7-mediated pathway may be just one of them.
How might neuronal Dmon1 regulate receptor expression? One possibility is that the increase in receptor levels is a postsynaptic homeostatic response to defects in neurotransmission, given that Dmon1 D181 mutants have smaller synaptic vesicles. However, in dvglut mutants, presence of smaller synaptic vesicles does not lead to any change in GluRIIA levels, given that receptors at the synapse are generally expressed at saturating levels (Daniels et al. 2006 ). Therefore, it seems unlikely that the increase in GluRIIA is part of a homeostatic response, although one cannot rule this out completely. The other possibility is that DMon1 is part of a transsynaptic signaling mechanism that regulates GluRIIA levels in a post-transcriptional manner. The observation that presynaptically expressed DMon1 localizes to postsynaptic regions ( Figure 7 ) and our results from neuronal RNAi and rescue experiments support this possibility. The involvement of transsynaptic signaling in regulating synaptic growth and function has been demonstrated in the case of signaling molecules such as Ephrins, Wingless, and Syt4 (Contractor et al. 2002; Korkut and Budnik 2009; Korkut et al. 2013) . In Drosophila, both Wingless and Syt4 are released by the presynaptic terminal via exosomes to mediate their effects in the postsynaptic compartment. We hypothesize that DMon1 released from the boutons either directly regulates GluRIIA levels or facilitates the release of an unknown factor required to maintain receptor levels. The function of DMon1 in the muscle is likely to be more consistent with its role in cellular trafficking and may mediate one of the pathways regulating GluRIIA turnover. These possibilities will need to be tested to gain a mechanistic understanding of receptor regulation by Dmon1.
